Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest update is out from Talis Biomedical (TLIS).
Talis Biomedical Corporation has struck a retention deal with Interim CFO Rebecca Markovich, offering her $89,250 to stay on board through major corporate transitions like a sale, merger, or dissolution. This move, which will be detailed in the company’s upcoming quarterly report, aims to ensure financial leadership stability during pivotal moments for the company’s future.
Find detailed analytics on TLIS stock on TipRanks’ Stock Analysis page.